Ron Bentsur - 07 Jul 2023 Form 4 Insider Report for Nuvectis Pharma, Inc. (NVCT)

Role
Chairman & CEO, Director, 10%+ Owner
Signature
/s/ Ron Bentsur
Issuer symbol
NVCT
Transactions as of
07 Jul 2023
Net transactions value
+$4,035
Form type
4
Filing time
18 Jul 2023, 08:34:39 UTC
Previous filing
07 Jul 2023
Next filing
20 Jul 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVCT Common Stock Purchase $1,781 +110 +0% $16.19 3,231,209 07 Jul 2023 Direct F1
transaction NVCT Common Stock Purchase $2,254 +150 +0% $15.03 3,231,359 14 Jul 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 426,759 shares of restricted stock.